Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
ESMO Immuno-Oncology Congress 2022: Who should take part in this event? - YouTube
Potential of immunotherapy in head and neck cancer | VJOncology
Finder | HCA UK
Professor Kevin Harrington - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
SAB and I-O AB - T3 Pharma
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
The ICR (@ICR_London) / Twitter
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
Loop | Kevin Joseph Harrington
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Amazon | Targeted Therapy for Cancer (Medicine) | Syrigos, Konstantinos N., Harrington, Kevin | Oncology
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
Prof. Kevin Harrington | HSTalks
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Potential of immunotherapy in head and neck cancer | VJOncology
Professor Kevin Harrington - YouTube
Professor Kevin Harrington, I [IMAGE] | EurekAlert! Science News Releases
Scientific Advisory Board – PsiVac
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Ducks Fan Harrington Continues His Cancer Fight
